BioSpace News Archive

A Phase 2b clinical trial involving more than 150 children and adolescents with Tourette syndrome found ecopipam significantly reduced the total number of tics compared to placebo, according to a study published today in the journal Pediatrics.

Medline Canada, Corporation announced the acquisition of Calgary-based Stat Healthcare Corporation, a medical and laboratory supplies provider with expertise in clinic set-ups.

MiNK Therapeutics, Inc. announced that Dr. Jennifer Buell, President and CEO of MiNK, will participate in a fireside chat at the 3rd Annual B. Riley Securities Oncology Conference on January 18th, at 11:00 AM ET.

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, presented pipeline and corporate updates at the 41st Annual J.P. Morgan Healthcare Conference.

Singulator™ 100 and Singulator™ 200 Systems and components to be available through local distributor in Spain and Portugal.

Eton Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s New Drug Application (NDA) response for dehydrated alcohol injection for the proposed indication of methanol poisoning.

InMode Ltd. announced today that it expects to release its financial results for the fourth quarter and full year 2022 before the Nasdaq market opens on Tuesday, February 14, 2023.

Bicycle Therapeutics plc today announced that monotherapy dose escalation results of the ongoing Phase I/II trial of BT8009, a second-generation BTC™ targeting Nectin-4, will be presented at the 2023 American Society for Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, being held February 16-18, 2023 in San Francisco, California.

CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium.

Nephros, Inc. today announced preliminary revenue results for the fourth quarter and fiscal year ended December 31, 2022.